| Tag | Content |
|---|
EnhancerAtlas ID | HS034-14246 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr19:1453610-1454290 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr19:1454017-1454036 | GGGCCAGCAGAGGGAGGCA | + | 6.39 | | SP2 | MA0516.2 | chr19:1453716-1453733 | ACACGCCCCACCCACTT | + | 6.18 | | SP8 | MA0747.1 | chr19:1453613-1453625 | AGTGGGCGTGGG | - | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_04580 | chr19:1448784-1454146 | Brain_Anterior_Caudate | | SE_07653 | chr19:1448648-1457040 | Brain_Hippocampus_Middle_150 | | SE_34483 | chr19:1453785-1454360 | HCT-116 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I001453 | chr19 | 1453601 | 1454394 |
|
Enhancer Sequence | GTGAGTGGGC GTGGGAACCC AGCCTCGGGC AGCTGGAGCA TGACTCGGTC CCCAGCGGGC 60
TCTGCCCTCT AATTCGCCCA CCCGCATATG TCTCTGCCCA CACCTCACAC GCCCCACCCA 120
CTTGCATATG GCACTGCCCA CCGAACAACC CCGCCCACCT CGGAGCTTCG TCCCCACGTG 180
GCCTCCCTCC CCCTCCCCAG CCCGGCTGAC CTCTGCTGGA GTTCAGAGAG GATGGGGGAC 240
GTTCCTGGCT GAGGGAAAGG CTCCTTGGAG ACGTCCCCAG GGGTCCGAGA CACGCAGGCG 300
TCGCCAGGGA CCGGGCTGTG TCCGGTGCCA GGGCTCAGCC AGGCCTGGAG CCAGGCGGGC 360
TCAAAGCCGT CTTTGTAGAG AGCTGTGGCC CAAGAAGCGT GGGCTCAGGG CCAGCAGAGG 420
GAGGCAGGGT CTGGGCACCC TGTGCAGCTG GGAGGGGTCA TGTGGGGTCA GATGGGGCCA 480
TTGAAGAGCA GCGTGGGGTT GTCTGTGCTC TGCTGTGGGA CCTCACTCAG CTCCCCTAAA 540
CCCTCCCAGC CTAAGACTCC TGCCCTGTAA AATCGGAATG GCCGTGTCTC CCATGAGGTT 600
AAGGGAAACC TCTGTTGCAC CTGGAGCACT TTGAGCCTGA AGCTACCTTG TAAGCTGGAG 660
GGAGGTTAGC AAGTATGGGA 680
|
